Showing 3961-3970 of 7540 results for "".
- Sun Pharma's New Ad Campaign Raises Awareness of Acne and its Impacthttps://practicaldermatology.com/news/sun-pharmas-new-ad-campaign-raises-awareness-of-acne-and-its-impact-1/2460280/Sun Dermatology, a division of Sun Pharmaceutical Industries, Inc., USA, launched Take on Acne – a new advertising campaign designed to raise awareness of the profound impact of acne on everyday life, particularly among teenagers and young adults (roughly 12-25 years of age). Acne af
- Resident of Distinction Award Celebrates 10th Anniversary at 2020 Caribbean Dermatology Symposiumhttps://practicaldermatology.com/news/resident-of-distinction-award-celebrates-10th-anniversary-at-2020-caribbean-dermatology-symposium/2460276/As part of the dermMentors Resident of Distinction Award, Beiersdorf Inc. sponsored five top dermatology residents to attend the 2020 Caribbean Dermatology Symposium, held in Paradise Island, Bahamas, from Jan. 21-25, 2020.
- Cold Plasma Patch May Make Immunotherapy More Effective for Treating Melanomahttps://practicaldermatology.com/news/cold-plasma-patch-may-make-immunotherapy-more-effective-for-treating-melanoma/2460275/A new medicated patch that can deliver immune checkpoint inhibitors and cold plasma directly to tumors may help boost the immune response and kill cancer cells, according to an interdisciplinary team of researchers at the UCLA Jonsson Comprehensive Cancer Center. The thumb-sized patch h
- BioPharmX Corporation and Timber Pharmaceuticals LLC Announce Mergerhttps://practicaldermatology.com/news/biopharmx-corporation-and-timber-pharmaceuticals-llc-announce-merger/2460267/BioPharmX Corporation and Timber Pharmaceuticals LLC have entered into a definitive merger agreement. Under the terms of the merger agreement, subject to the approval of BioPharmX's stockholders and Timber's members, a wholly-owned subsidiary of BioPharmX will be merged wit
- SU2C Calls for Increased Diversity in Cancer Trialshttps://practicaldermatology.com/news/su2c-calls-for-increased-diversity-in-cancer-trials/2460265/Stand Up to Cancer (SU2C) announced a new diversity initiative that aims to make sure current advances in diagnosing and treating cancers don’t leave anyone out. The lack of diverse participation in cancer clinical trials may be due to socio-economic, cultural, trust and
- Crown Aesthetics Introduces Progen PRP Advantagehttps://practicaldermatology.com/news/crown-aesthetics-introduces-progen-prp-advantage/2460263/Crown Aesthetics, a division of Crown Laboratories, Inc., launched ProGen PRP Advantage, an easy-to-use, single-spin system that features 15ml and 30ml tubes, yielding 7-15ml of 2x concentration PRP. With the launch of
- Cynosure Taps Todd Tillemans As New CEOhttps://practicaldermatology.com/news/cynosure-taps-todd-tillemans-as-new-ceo-2/2460262/Todd Tillemans is the new Chief Executive Officer of Cynosure, LLC. Mr. Tillemans is the former President of Hershey's flagship U.S. business generating more than $6.5 billion in annual sales. Prior to that, he held various leadership positions across Unilever's
- Get to Know the Newly Restructured Crown Laboratorieshttps://practicaldermatology.com/news/get-to-know-the-newly-restructured-crown-laboratories/2460256/Crown Laboratories has restructured its commercial operations business units as it continues to elevate its new “Skin Science for Life” commitment. For the past two years, Crown says it has been dedicated to transforming its Northeast Tennessee operations into a global skinc
- South Beach Symposium Poised for 18th Miami Conferencehttps://practicaldermatology.com/news/south-beach-symposium-poised-for-18th-miami-conference/2460253/The 18th Annual South Beach Symposium takes place in Miami Beach next month. Organizers say the annual conference boasts an extensive agenda, with in-depth pre-conference offerings, and sessions topics covering the latest and most well-supported knowledge in clinical and aesthetic dermatology. Ro
- Revian Awarded Patent for Biostimulatory Light Combinationshttps://practicaldermatology.com/news/revian-awarded-patent-for-biostimulatory-light-technology/2460249/Revian Inc. has received from the United States Patent and Trademark Office (USPTO) U.S. Patent No. 10,265,258—the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body. The claims in this issued patent cover the u